Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, non-clinical safety evaluation, non-clinical pharmacokinetic studies, non-clinical pharmacodynamic studies, clinical testing, and translational research. The company was founded on May 12, 2010 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company